GALT - Galectin Therapeutics Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical stage biopharmaceutical company. The company is engaged in drug research and development to create new therapies for fibrotic disease and cancer.
IPO Date: October 1, 2002
Sector: Healthcare
Industry: Biotech
Related Tickers:
AMGN GILD VRTX REGN MRNA ARGX ONC IQV RVMD BIIB
Market Cap: $316.67M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.16 | 4.35%
Avg Daily Range (30 D): $0.13 | 3.74%
Avg Daily Range (90 D): $0.16 | 4.25%
Institutional Daily Volume
Avg Daily Volume: .35M
Avg Daily Volume (30 D): .17M
Avg Daily Volume (90 D): .28M
Trade Size
Avg Trade Size (Sh.): 237
Avg Trade Size (Sh.) (30 D): 107
Avg Trade Size (Sh.) (90 D): 107
Institutional Trades
Total Institutional Trades: 56
Avg Institutional Trade: $2.27M
Avg Institutional Trade (30 D): $1.96M
Avg Institutional Trade (90 D): $1.96M
Avg Institutional Trade Volume: .46M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $4.46M
Avg Closing Trade (30 D): $1.96M
Avg Closing Trade (90 D): $1.96M
Avg Closing Volume: 1.02M
 
News
May 27, 2026 @ 12:00 PM
Galectin Therapeutics Presents New EASL 2026 Oral ...
Source: Na
Nov 14, 2025 @ 1:00 PM
Galectin Therapeutics Reports Financial Results fo...
Source: Galectin Therapeutics
Jun 10, 2025 @ 12:56 PM
Galectin Therapeutics to Host Virtual KOL Event to...
Source: N/A
Jan 10, 2025 @ 1:00 PM
Galectin Therapeutics to Present at the 2025 MASH-...
Source: N/A
Aug 13, 2024 @ 12:00 PM
Galectin Therapeutics Reports Financial Results fo...
Source: N/A
Splits
Mar 23, 2012 1:6